Taysha Gene Therapies Inc [NASDAQ: TSHA] stock went on a downward path that fall over -12.42% on Monday, amounting to a one-week price decrease of less than -31.98%.
Over the last 12 months, TSHA stock dropped by -44.17%. The one-year Taysha Gene Therapies Inc stock forecast points to a potential upside of 79.1. The average equity rating for TSHA stock is currently 1.09, trading closer to a bullish pattern in the stock market.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for the stock reached $248.62 million, with 186.96 million shares outstanding and 158.49 million shares in the current float. Compared to the average trading volume of 1.61M shares, TSHA stock reached a trading volume of 7446056 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Taysha Gene Therapies Inc [TSHA]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TSHA shares is $6.41 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TSHA stock is a recommendation set at 1.09. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
BMO Capital Markets have made an estimate for Taysha Gene Therapies Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on June 27, 2024. While these analysts kept the previous recommendation, Piper Sandler raised their target price to Overweight. The new note on the price target was released on April 09, 2024, representing the official price target for Taysha Gene Therapies Inc stock. Previously, the target price had yet another drop from $14 to $1.50, while Jefferies kept a Hold rating on TSHA stock. On January 27, 2023, analysts decreased their price target for TSHA shares from 23 to 3.
The Average True Range (ATR) for Taysha Gene Therapies Inc is set at 0.11, with the Price to Sales ratio for TSHA stock in the period of the last 12 months amounting to 19.32. The Price to Book ratio for the last quarter was 2.48, with the Price to Cash per share for the same quarter was set at 0.93.
TSHA Stock Performance Analysis:
Taysha Gene Therapies Inc [TSHA] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -31.98. With this latest performance, TSHA shares dropped by -33.33% in over the last four-week period, additionally sinking by -48.85% over the last 6 months – not to mention a drop of -44.17% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TSHA stock in for the last two-week period is set at 15.63, with the RSI for the last a single of trading hit 8.48, and the three-weeks RSI is set at 22.62 for Taysha Gene Therapies Inc [TSHA]. The present Moving Average for the last 50 days of trading for this stock 2.0384, while it was recorded at 1.6620 for the last single week of trading, and 2.3874 for the last 200 days.
Insight into Taysha Gene Therapies Inc Fundamentals:
Taysha Gene Therapies Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.20 and a Current Ratio set at 5.20.
Taysha Gene Therapies Inc [TSHA] Institutonal Ownership Details
There are presently around $78.07%, or 94.67%% of TSHA stock, in the hands of institutional investors. The top three institutional holders of TSHA stocks are: FMR LLC with ownership of 21.21 million shares, which is approximately 9.1722%. RTW INVESTMENTS, LP, holding 18.8 million shares of the stock with an approximate value of $$42.11 million in TSHA stocks shares; and RTW INVESTMENTS, LP, currently with $$41.78 million in TSHA stock with ownership which is approximately 8.0649%.
